Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1944-446X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics ; volume:35 ; number:1 ; day:29 ; month:6 ; year:2016 ; pages:1-10 ; date:12.2016
Chinese journal of cancer ; 35, Heft 1 (29.6.2016), 1-10, 12.2016
- Urheber
-
Fuso Nerini, Ilaria
- Beteiligte Personen und Organisationen
-
Cesca, Marta
Bizzaro, Francesca
Giavazzi, Raffaella
SpringerLink (Online service)
- DOI
-
10.1186/s40880-016-0123-1
- URN
-
urn:nbn:de:1111-2016070111576
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fuso Nerini, Ilaria
- Cesca, Marta
- Bizzaro, Francesca
- Giavazzi, Raffaella
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors
Pharmacokinetics and Pharmacodynamics of PARP Inhibitors in Oncology
Clinical Pharmacokinetics and Pharmacodynamics of Evolocumab, a PCSK9 Inhibitor
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Pharmacokinetics and Pharmacodynamics of Posaconazole
Journal of pharmacokinetics and pharmacodynamics
Pharmacokinetics and Pharmacodynamics of Ibrexafungerp
Pharmacokinetics and Pharmacodynamics of Tedizolid
Clinical Pharmacokinetics and Pharmacodynamics of Afatinib
Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib
Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide
Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine
Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors
Pharmacokinetics and Pharmacodynamics of PARP Inhibitors in Oncology
Clinical Pharmacokinetics and Pharmacodynamics of Evolocumab, a PCSK9 Inhibitor
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Pharmacokinetics and Pharmacodynamics of Posaconazole
Journal of pharmacokinetics and pharmacodynamics
Pharmacokinetics and Pharmacodynamics of Ibrexafungerp
Pharmacokinetics and Pharmacodynamics of Tedizolid
Clinical Pharmacokinetics and Pharmacodynamics of Afatinib
Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib
Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide
Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine
Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors
Pharmacokinetics and Pharmacodynamics of PARP Inhibitors in Oncology
Clinical Pharmacokinetics and Pharmacodynamics of Evolocumab, a PCSK9 Inhibitor
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Pharmacokinetics and Pharmacodynamics of Posaconazole
Journal of pharmacokinetics and pharmacodynamics
Pharmacokinetics and Pharmacodynamics of Ibrexafungerp
Pharmacokinetics and Pharmacodynamics of Tedizolid
Clinical Pharmacokinetics and Pharmacodynamics of Afatinib
Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib
Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide